Policy incentives drive the vigorous development of innovative research and development in traditional Chinese medicine.
Release date:
2025-03-01
The country has introduced a series of policy measures aimed at encouraging innovation and R&D in traditional Chinese medicine, injecting strong momentum into the development of the TCM industry.
The country has introduced a series of policy measures aimed at encouraging innovation and R&D in traditional Chinese medicine, injecting strong momentum into the industry's growth. These policies cover multiple areas, including increasing investment in scientific research, streamlining approval processes, and fostering collaboration among industry, academia, and research institutions. With robust policy support, numerous TCM enterprises have stepped up their R&D efforts, partnering with leading research organizations to pioneer the development of innovative TCM drugs. Recently, several groundbreaking TCM products—each backed by independent intellectual property rights—have received approval for clinical trials, showcasing remarkable advantages in treating chronic and complex diseases. The thriving wave of TCM innovation and R&D not only helps preserve and promote the rich heritage of traditional Chinese medicine but also promises to deliver safer, more effective treatment options to the global pharmaceutical market.
Related News
Company Address: Zone C, Specialized & Innovative Chemical Industry Incubation Base, West Section of Yili River Street, No. 436, Qinchuan Town, Qinchuan Park, Lanzhou New Area, Gansu Province
Mobile Phone Official Website